Samia Sultana Lira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Samia Sultana Lira has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ishtiaque Ahammad
National Institute of Biotechnology
2 shared publications Alex N Lagasse
University of Arkansas for Medical Sciences, College of Medicine , Little Rock, AR , USA
1 shared publication- Angela Katherine Odle
Department of Neuroscience, University of Arkansas for Medical Sciences, 4301 W Markham, Slot 814, Little Rock, AR 72205, USA
1 shared publication - Angus M. MacNicol
Department of Neuroscience, University of Arkansas for Medical Sciences, 4301 W Markham, Slot 814, Little Rock, AR 72205, USA
1 shared publication - Gwen V. Childs
Department of Neuroscience, University of Arkansas for Medical Sciences , Little Rock, AR 72205
1 shared publication - Melanie C. MacNicol
Department of Neuroscience, University of Arkansas for Medical Sciences, Little Rock, AR, 72205
1 shared publication
Latest Publications
- Open Access
- 5 October 2023
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 7 (Supplement)
THU043 Single-cell Transcriptomics Show Sex-specific Responses To A High Fat Diet, Under Thermoneutral Conditions, Pointing To Reduced Pituitary Plasticity
Disclosure: T.K. Miles: None. A.N. Lagasse: None. A.K. Odle: None. S.S. Lira: None. M.M. Syed: None. N. Akhter: None. M.C. MacNicol: None. A.M. MacNicol: None. G.V. Childs: None. Hyperinsulinemia caused by a high fat diet (HFD) directly suppressed pituitary growth hormone (Gh) and growth hormone releasing hormone receptor (Ghrhr) mRNAs (Luque and Kineman, 2006). To study the broader impact of a HFD, we exposed 3 groups of FVB.129P mice to 60% HFD for 10 or 15 wks at thermoneutrality (TN) (30 C), or 15 wks at room temperature (RT). Pituitary transcript expression was analyzed with single-cell RNA-seq. HFD-fed mice gained >20 g by 12 wks, showing increased serum leptin (1.8-2X), insulin (2-8X) and IL-6 (4-6X), decreased glucose clearance after a glucose challenge and decreased respiratory quotient indicating fat burning. Activity was unaffected by HFD. Rank plot analyses showed reduced amplitude GH pulses in HFD females fed at RT (15 wks), but not in mice fed at TN. Serum levels of other pituitary hormones were unaffected in HFD females. In HFD males, only serum TSH was elevated significantly (1.8X, 15 wks, TN). Analysis of the scRNA-seq data detected separate clusters representing each cell type. Two multihormonal cell clusters evident in control females mostly disappeared following HFD (15 wks, RT). At the threshold cutoff of avg Log2FC±0.5 with adj p20 were involved with signaling and cell differentiation. In males, whereas changes in most clusters fell below the threshold cutoffs, stem cell clusters had 13 reduced transcripts after 10 or 15 weeks, most of which involved immune system processes including defense responses and antigen processing and presentation. The GH deficiency in mice fed under thermoneutral conditions was not as severe as that reported by Luque and Kineman, perhaps due to differences in strain, sex, and/or the environmental temperature. The reduced expression of multihormonal clusters, Gh by lactotropes and corticotropes, and Cga and Pomc by somatotropes suggests that HFD may reduce plasticity and activity of progenitor cells in the pituitary. The changes in lactotropes and somatotropes also indicate that HFD may compromise ribosome function and cytoplasmic translation. The reduced transcriptome in stem cells in both males and females suggests HFD interference with cell differentiation and pituitary plasticity as well as dysfunctional immune defense responses. Presentation: Thursday, June 15, 2023
- 5 October 2023
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 7 (Supplement)
Open AccessTHU043 Single-cell Transcriptomics Show Sex-specific Responses To A High Fat Diet, Under Thermoneutral Conditions, Pointing To Reduced Pituitary Plasticity
Disclosure: T.K. Miles: None. A.N. Lagasse: None. A.K. Odle: None. S.S. Lira: None. M.M. Syed: None. N. Akhter: None. M.C. MacNicol: None. A.M. MacNicol: None. G.V. Childs: None. Hyperinsulinemia caused by a high fat diet (HFD) directly suppressed pituitary growth hormone (Gh) and growth hormone releasing hormone receptor (Ghrhr) mRNAs (Luque and Kineman, 2006). To study the broader impact of a HFD, we exposed 3 groups of FVB.129P mice to 60% HFD for 10 or 15 wks at thermoneutrality (TN) (30 C), or 15 wks at room temperature (RT). Pituitary transcript expression was analyzed with single-cell RNA-seq. HFD-fed mice gained >20 g by 12 wks, showing increased serum leptin (1.8-2X), insulin (2-8X) and IL-6 (4-6X), decreased glucose clearance after a glucose challenge and decreased respiratory quotient indicating fat burning. Activity was unaffected by HFD. Rank plot analyses showed reduced amplitude GH pulses in HFD females fed at RT (15 wks), but not in mice fed at TN. Serum levels of other pituitary hormones were unaffected in HFD females. In HFD males, only serum TSH was elevated significantly (1.8X, 15 wks, TN). Analysis of the scRNA-seq data detected separate clusters representing each cell type. Two multihormonal cell clusters evident in control females mostly disappeared following HFD (15 wks, RT). At the threshold cutoff of avg Log2FC±0.5 with adj p20 were involved with signaling and cell differentiation. In males, whereas changes in most clusters fell below the threshold cutoffs, stem cell clusters had 13 reduced transcripts after 10 or 15 weeks, most of which involved immune system processes including defense responses and antigen processing and presentation. The GH deficiency in mice fed under thermoneutral conditions was not as severe as that reported by Luque and Kineman, perhaps due to differences in strain, sex, and/or the environmental temperature. The reduced expression of multihormonal clusters, Gh by lactotropes and corticotropes, and Cga and Pomc by somatotropes suggests that HFD may reduce plasticity and activity of progenitor cells in the pituitary. The changes in lactotropes and somatotropes also indicate that HFD may compromise ribosome function and cytoplasmic translation. The reduced transcriptome in stem cells in both males and females suggests HFD interference with cell differentiation and pituitary plasticity as well as dysfunctional immune defense responses. Presentation: Thursday, June 15, 2023
- Open Access
A comprehensive in silico investigation into the nsSNPs of Drd2 gene predicts significant functional consequences in dopamine signaling and pharmacotherapy
DRD2 is a neuronal cell surface protein involved in brain development and function. Variations in the Drd2 gene have clinical significance since DRD2 is a pharmacotherapeutic target for treating psychiatric disorders like ADHD and schizophrenia. Despite numerous studies on the disease association of single nucleotide polymorphisms (SNPs) in the intronic regions, investigation into the coding regions is surprisingly limited. In this study, we aimed at identifying potential functionally and pharmaco-therapeutically deleterious non-synonymous SNPs of Drd2 . A wide array of bioinformatics tools was used to evaluate the impact of nsSNPs on protein structure and functionality. Out of 260 nsSNPs retrieved from the dbSNP database, initially 9 were predicted as deleterious by 15 tools. Upon further assessment of their domain association, conservation profile, homology models and inter-atomic interaction, the mutant F389V was considered as the most impactful. In-depth analysis of F389V through Molecular Docking and Dynamics Simulation revealed a decline in affinity for its native agonist dopamine and an increase in affinity for the antipsychotic drug risperidone. Remarkable alterations in binding interactions and stability of the protein-ligand complex in simulated physiological conditions were also noted. These findings will improve our understanding of the consequence of nsSNPs in disease-susceptibility and therapeutic efficacy.
Open AccessA comprehensive in silico investigation into the nsSNPs of Drd2 gene predicts significant functional consequences in dopamine signaling and pharmacotherapy
DRD2 is a neuronal cell surface protein involved in brain development and function. Variations in the Drd2 gene have clinical significance since DRD2 is a pharmacotherapeutic target for treating psychiatric disorders like ADHD and schizophrenia. Despite numerous studies on the disease association of single nucleotide polymorphisms (SNPs) in the intronic regions, investigation into the coding regions is surprisingly limited. In this study, we aimed at identifying potential functionally and pharmaco-therapeutically deleterious non-synonymous SNPs of Drd2 . A wide array of bioinformatics tools was used to evaluate the impact of nsSNPs on protein structure and functionality. Out of 260 nsSNPs retrieved from the dbSNP database, initially 9 were predicted as deleterious by 15 tools. Upon further assessment of their domain association, conservation profile, homology models and inter-atomic interaction, the mutant F389V was considered as the most impactful. In-depth analysis of F389V through Molecular Docking and Dynamics Simulation revealed a decline in affinity for its native agonist dopamine and an increase in affinity for the antipsychotic drug risperidone. Remarkable alterations in binding interactions and stability of the protein-ligand complex in simulated physiological conditions were also noted. These findings will improve our understanding of the consequence of nsSNPs in disease-susceptibility and therapeutic efficacy.
- 1 November 2020
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 162, 820-837
Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach
- 1 November 2020
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 162, 820-837
Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach